T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Dream Finders Homes
DFH
$1.35B
| $231K | ﹤0.01% |
8,908
+1,973
| +28% | +$62.4K |
|
|
PVBC
2527
DELISTED
Provident Bancorp
PVBC
| $231K | ﹤0.01% |
22,645
+5,045
| +29% | +$46.5K |
|
|
SNBR
2528
DELISTED
Sleep Number
SNBR
| $231K | ﹤0.01% |
24,121
+3,999
| +20% | +$54.7K |
|
2529
Cipher Digital
CIFR
$6.9B
| $229K | ﹤0.01% |
54,984
+43,676
| +386% | +$181K |
|
|
LOVE
2530
LoveSac
LOVE
$258M
| $229K | ﹤0.01% |
10,129
+496
| +5% | +$12K |
|
|
OLO
2531
DELISTED
Olo Inc
OLO
| $229K | ﹤0.01% |
51,805
+3,565
| +7% | +$16.9K |
|
2532
Anavex Life Sciences
AVXL
$303M
| $228K | ﹤0.01% |
53,795
+2,021
| +4% | +$8.18K |
|
|
VISN
2533
Vistance Networks Inc
VISN
$2.62B
| $227K | ﹤0.01% |
183,902
+34,675
| +23% | +$41.3K |
|
2534
Axogen
AXGN
$2.58B
| $226K | ﹤0.01% |
31,173
+1,523
| +5% | +$10.4K |
|
2535
Nektar Therapeutics
NKTR
$2.57B
| $226K | ﹤0.01% |
12,136
+3,819
| +46% | +$80.5K |
|
2536
Park-Ohio Holdings
PKOH
$718M
| $226K | ﹤0.01% |
8,703
| – | – |
|
2537
F&G Annuities & Life
FG
$3.59B
| $225K | ﹤0.01% |
5,901
+530
| +10% | +$20.8K |
|
2538
Hingham Institution for Saving
HIFS
$686M
| $225K | ﹤0.01% |
1,256
-30
| -2% | -$5.18K |
|
2539
IMAX
IMAX
$2.92B
| $225K | ﹤0.01% |
13,415
+333
| +3% | +$5.51K |
|
2540
Costamare
CMRE
$1.74B
| $224K | ﹤0.01% |
13,622
-59
| -0.4% | -$806 |
|
|
EU
2541
enCore Energy
EU
$221M
| $224K | ﹤0.01% |
56,767
+10,182
| +22% | +$45K |
|
|
IAS
2542
DELISTED
Integral Ad Science
IAS
| $224K | ﹤0.01% |
23,019
+3,804
| +20% | +$36.4K |
|
2543
Fulcrum Therapeutics
FULC
$283M
| $222K | ﹤0.01% |
35,712
+19,812
| +125% | +$150K |
|
2544
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $222K | ﹤0.01% |
+11,882
| New | +$223K |
|
2545
Merchants Bancorp
MBIN
$2.54B
| $222K | ﹤0.01% |
5,458
+795
| +17% | +$32.6K |
|
2546
Atea Pharmaceuticals
AVIR
$406M
| $221K | ﹤0.01% |
66,660
-477
| -0.7% | -$1.78K |
|
2547
Liquidia Corp
LQDA
$6.45B
| $221K | ﹤0.01% |
18,357
+4,016
| +28% | +$53.3K |
|
2548
Aehr Test Systems
AEHR
$4.02B
| $220K | ﹤0.01% |
19,668
+3,650
| +23% | +$42.5K |
|
2549
Pangaea Logistics
PANL
$496M
| $220K | ﹤0.01% |
27,998
| – | – |
|
2550
Aveanna Healthcare
AVAH
$2.46B
| $219K | ﹤0.01% |
79,201
+5,140
| +7% | +$12.8K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.